• N/A
    Market Cap
  • -83.33%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 17
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.

Fifty 1 Labs Inc. has signed a Letter of Intent to acquire BioSpark AI Technologies Inc., a Vancouver-based AI company specializing in clinical data extraction and analysis. The proposed acquisition involves 25 million common shares and aims to strengthen Fifty 1 Labs' position in AI-powered healthcare solutions.

09/30/2025, 9:56 AM • Benzinga

Peers

Statistics

More
Day Range
$0.0003
$0.0004
$0.0003
1-Year Range
$0.0002
$0.006
$0.0003
Latest Close$0.0003
Change
-$0.0001 (-33.33%)
Volume6,177,783

Information as of 06/03/2026

Company Profile

FIFTY 1 LABS INC
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

FIFTY 1 LABS INC

Key Executives

  • Joel Gagnier
  • Nima Sakian
  • Martin Mills
  • Richard Robins
  • Alind Gupta

Current Ownership Distribution

  • Other571.9M (100.00%)
  • Insiders9,500 (0.002%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)